Healthcare at Home
Financials
Estimates*
| GBP | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 1.6b | 1.7b | 1.8b | 1.4b | 1.9b | 1.5b | 1.6b |
| % growth | 14 % | 10 % | 5 % | (26 %) | - | (21 %) | 9 % |
| EBITDA | 4.5m | 11.9m | 16.4m | 16.8m | 22.0m | 20.8m | 19.6m |
| % EBITDA margin | - | 1 % | 1 % | 1 % | 1 % | 1 % | 1 % |
| Profit | 1.3m | 8.0m | 10.1m | 13.5m | 20.2m | 12.4m | 10.4m |
| % profit margin | - | - | 1 % | 1 % | 1 % | 1 % | 1 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Acquisition | ||
| N/A | N/A | Growth Equity non VC | |
| Total Funding | - | ||
Related Content
Recent News about Healthcare at Home
EditHealthcare at Home is a leading provider of clinical healthcare services delivered outside of traditional hospital settings. The company caters to a diverse range of clients, including patients at home, employees at work, and individuals within communities. Operating primarily in the UK healthcare market, Healthcare at Home collaborates with publicly funded health systems, private health systems, and pharmaceutical partners to offer comprehensive healthcare solutions. The business model revolves around providing personalized healthcare services directly to patients, thereby reducing the need for hospital visits and enhancing patient convenience. Revenue is generated through partnerships with health systems and pharmaceutical companies, as well as direct patient services. The company is highly recommended, with 93% of patients willing to recommend its services to friends and relatives, highlighting its commitment to quality and patient satisfaction.
Keywords: clinical healthcare, out-of-hospital, home care, patient convenience, UK market, health systems, pharmaceutical partners, personalized services, patient satisfaction, healthcare solutions.